Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Non-Squamous Non-Small Cell Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00002901
What this trial is testing

Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function

Who this might be right for
Breast CancerHead and Neck CancerLung Cancer+2 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00006877
What this trial is testing

Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Case Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT01824901
What this trial is testing

Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerSquamous Cell Lung Cancer
ECOG-ACRIN Cancer Research Group 2
Large-scale testing (Phase 3)Looking for participantsNCT07660094
What this trial is testing

Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)

Who this might be right for
Non-squamous, Non-Small Cell Lung Cancer
Candel Therapeutics, Inc. 500
Early research (Phase 1)Ended earlyNCT05576077
What this trial is testing

TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerUveal Melanoma+3 more
Turnstone Biologics, Corp. 31
Not applicableStudy completedNCT00533884
What this trial is testing

Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic

Who this might be right for
Neurocognitive ImpairmentDeliriumEsophageal Cancer+2 more
Vanderbilt University Medical Center 86
Large-scale testing (Phase 3)UnknownNCT02780778
What this trial is testing

Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 20
Testing effectiveness (Phase 2)UnknownNCT05117138
What this trial is testing

Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerHead and Neck Squamous Cell Carcinoma
Beijing Immunochina Medical Science & Technology Co., Ltd. 39
Testing effectiveness (Phase 2)Ended earlyNCT02452463
What this trial is testing

Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy

Who this might be right for
Lung Non-Squamous Non-Small Cell CarcinomaRadiation-Induced PneumonitisStage II Lung Non-Small Cell Cancer AJCC v7+6 more
Roswell Park Cancer Institute 8
Testing effectiveness (Phase 2)UnknownNCT05094804
What this trial is testing

OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

Who this might be right for
CancerTumor, SolidMalignant Neoplasm+7 more
OncoResponse, Inc. 172
Large-scale testing (Phase 3)Active Not RecruitingNCT06711900
What this trial is testing

SKB264 in Combination With Pembrolizumab Versus Chemotherapy in Combination With Pembrolizumab as First-Line Treatment for PD-L1 Negative Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 432
Large-scale testing (Phase 3)Study completedNCT00079287
What this trial is testing

Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Japan Multinational Trial Organization
Early research (Phase 1)Active Not RecruitingNCT04603287
What this trial is testing

SI-B001, an EGFR/HER3 Bispecific Antibody, in Locally Advanced or Metastatic Epithelial Tumors

Who this might be right for
Locally Advanced or Metastatic Epithelial Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Ended earlyNCT00438204
What this trial is testing

Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Barbara Ann Karmanos Cancer Institute 39
Large-scale testing (Phase 3)Study completedNCT02657434
What this trial is testing

Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 578
Not applicableStudy completedNCT02972216
What this trial is testing

Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy

Who this might be right for
Nonsmall Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck
Yung Shin Pharm. Ind. Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT00563784
What this trial is testing

TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung CancerLung Cancer
M.D. Anderson Cancer Center 68
Early research (Phase 1)Looking for participantsNCT06465069
What this trial is testing

LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Who this might be right for
Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more
Eli Lilly and Company 420
Testing effectiveness (Phase 2)Study completedNCT00117962
What this trial is testing

Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 109
Testing effectiveness (Phase 2)Ended earlyNCT03094169
What this trial is testing

AVID100 in Advanced Epithelial Carcinomas

Who this might be right for
Solid Tumor, AdultTriple Negative Breast CancerHead and Neck Squamous Cell Carcinoma+1 more
Formation Biologics 49
Next Page